Magna Laboratories (Gujarat).Ltd. Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 22-12-2024
- Paid Up Capital ₹ 2.50 M
as on 22-12-2024
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -99.96%
(FY 2020)
- Profit -122.44%
(FY 2020)
- Ebitda 62.77%
(FY 2020)
- Net Worth -2.21%
(FY 2020)
- Total Assets -40.24%
(FY 2020)
About Magna Laboratories (Gujarat).Ltd.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Meera Gandhi and Sachin Gandhi serve as directors at the Company.
- CIN/LLPIN
U99999MH1986PTC039769
- Company No.
039769
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Magna Laboratories (Gujarat).Ltd.?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Gandhi  | Managing Director | 08-May-1986 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meera Gandhi | Director | 04-Feb-1992 | Current |
Financial Performance of Magna Laboratories (Gujarat).Ltd..
Magna Laboratories (Gujarat) Pvt.Ltd., for the financial year ended 2020, experienced significant reduction in revenue, with a 99.96% decrease. The company also saw a substantial fall in profitability, with a 122.44% decrease in profit. The company's net worth dipped by a decrease of 2.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magna Laboratories (Gujarat).Ltd.?
In 2019, Magna Laboratories (Gujarat).Ltd. had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vital Healthcare Private LimitedActive 32 years 2 monthsMeera Gandhi and Sachin Gandhi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Magna Laboratories (Gujarat).Ltd.?
Magna Laboratories (Gujarat).Ltd. has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magna Laboratories (Gujarat).Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magna Laboratories (Gujarat).Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
